<DOC>
	<DOCNO>NCT02765737</DOCNO>
	<brief_summary>Multicenter , prospective , randomize , control feasibility trial determine safety effectiveness Dehydrated Human Amnion Chorion Membrane ( dHACM ) plus Control compare Control alone treatment second degree burn assess time heal scar</brief_summary>
	<brief_title>Dehydrated Human Amnion Chorion Membrane ( dHACM ) vs. Control Treatment Partial Thickness Burns .</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<criteria>patient enrol must meet following criterion : 1 . Patient burn injury meet follow requirement : 1 . Occurred within last 48 hour 2 . Wound thermal nature 3 . Partialthickness burn ( burn extend epidermis may penetrate dermis ) 4 . Total body surface area ( TBSA ) burn ( ) 220 % subject 5 . Burn area ( ) locate smooth , flat surface 6 . 2 burn area , minimum size 16cm2 ( burn area may two separate burn within one large burn , see Section 9.4.2 ) 2 . Age ≥ 12 month ≤ 70 year Subjects meeting follow criterion exclude : 1 . Burns meet follow criterion : 1 . Mechanism injury electrical , radiation , chemical frostbite 2 . Wound large 200 cm2 3 . Clinically infected burn ( judged investigator ) 4 . Previous plan treatment Burn Area ( ) following : Biological Skin Substitutes ( include Apligraf® , Dermagraft® , etc . ) 2 . Patient criterion make patient ineligible enrollment : 1 . Ventilator dependence 2 . Active malignant disease patient le 1 year diseasefree 3 . Use immunosuppressive agent , radiation chemotherapy within past 30 day 4 . Autoimmune disorder include Systemic Lupus Erythematosus ( SLE ) , Fibromyalgia , Acquired Immunodeficiency Syndrome ( AIDS ) Human Immunodeficiency Virus ( HIV ) 5 . Presence condition ( include current drug alcohol abuse , medical psychiatric condition ) likely impair understand compliance study protocol judgment Investigator 6 . Presence condition likely compromise heal judgment Investigator 7 . Pregnancy enrollment within last 6 month , woman breastfeed , woman childbearing potential planning become pregnant time study OR unwilling/unable use acceptable method contraception ( birth control pill , barrier , abstinence ) 8 . Patient investigational drug ( ) therapeutic device ( ) last 30 day previous enrollment study 3 . Allergy known sensitivity follow : 1 . Aminoglycosides gentamicin sulfate and/or streptomycin sulfate 2 . Silver</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>